AHG · Akso Health Group
Market Cap
$734.02M
Shares
856.70M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$13.83M
-6.4%
FY2026
Net Income
-$18.67M
+86.2%
FY2026
Gross Margin
-0.08%
+1.8pp
FY2026
Operating Margin
-149.66%
+975.7pp
FY2026
Diluted EPS
$0.01
-93.8%
FY2026
Operating Cash Flow
-$12.79M
-1186.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $13.83M | $14.78M | $2.41M | $13.18M | $6M | $1.75M | $6.91M | $3.7M | $107.26M | $22.92M | — | |
| — | — | — | — | — | — | — | — | $590.12K | — | — | |
| $13.84M | $15.06M | $2.29M | $11.91M | $5.39M | $544.57K | $1.03M | $7.4M | $8.5M | $5.15M | — | |
| -$11.32K | -$281.53K | $122.13K | $1.27M | $605.13K | $1.75M | $6.91M | — | $107.26M | $22.92M | $11.89M | |
| -0.08% | -1.91% | 5.06% | 9.63% | 10.09% | 100% | 100% | — | 100% | 100% | — | |
| — | — | — | — | $421.19K | $441.41K | $117.94K | $0 | $2.82M | $1.57M | $895.99K | |
| — | — | $168.42K | $6661 | $240.93K | $1.09M | $1.46M | $1.17M | $15.24M | $5.21M | $3.84M | |
| $3.99M | $3.64M | $8.59M | $15.53M | $2.67M | $2.03M | $20.49M | $3.13M | $5.82M | $2.65M | $1.55M | |
| $3.99M | $3.64M | $8.59M | — | — | — | — | — | — | — | — | |
| $2.36M | $2.15M | — | — | — | — | — | — | — | — | — | |
| $2.37M | $2.15M | — | — | $18.39K | $15.16K | $120.52K | $17.23K | $174.38K | $92.22K | $61.39K | |
| $20.69M | $166.02M | $8.76M | $15.54M | $3.87M | $4.24M | $55.02M | — | $31.38M | $13.01M | $7.75M | |
| — | — | — | — | — | $32.66M | $55.02M | $10.88M | $31.38M | $13.01M | — | |
| -$20.7M | -$166.3M | -$8.64M | -$14.27M | -$3.26M | -$4.24M | -$48.11M | -$7.19M | $75.88M | $9.91M | $4.14M | |
| -149.66% | -1125.37% | -357.78% | -108.23% | -54.34% | -241.68% | -695.72% | -194.55% | 70.74% | 43.25% | — | |
| -$18.33M | -$164.15M | — | — | -$3.24M | -$4.23M | -$47.99M | -$7.17M | $76.05M | $10.01M | $4.2M | |
| — | — | — | — | $804.14K | $2.15M | — | — | — | — | — | |
| -$4113 | $34.07K | -$453.75K | $1.2M | -$747.82K | -$52.08K | $1.23M | $381.15K | $660.88K | $179.53K | $26.27K | |
| -$20.7M | -$166.27M | -$9.09M | -$13.07M | -$4.01M | -$4.29M | -$46.87M | -$6.81M | $76.54M | $10.09M | $4.17M | |
| -$1.99M | -$30.8M | $24.99K | $17.55K | $92.82K | $482.98K | $489.96K | $807.71K | $11.03M | $1.52M | $628.25K | |
| -$18.67M | -$134.98M | -$9.46M | -$1.36M | -$16.85M | -$34.83M | -$71.2M | $5.53M | $65.48M | $8.57M | $3.54M | |
| -134.99% | -913.38% | -391.78% | -10.32% | -280.85% | -1984.52% | -1029.7% | 149.72% | 61.05% | 37.39% | — | |
| -$44.57K | -$491.76K | -$57.79K | $112.5K | $1331 | — | — | — | $28.65K | — | — | |
| -$18.67M | -$134.98M | -$9.46M | — | — | — | -$71.2M | $5.53M | $65.48M | $8.57M | $3.54M | |
| -$18.18M | -$134.66M | -$9.7M | -$3.45M | -$15.4M | -$30.88M | -$76.49M | -$603.61K | $71.41M | $7.49M | $3.06M | |
| USD/shares | $0.01 | $0.16 | $0.07 | -$0.02 | -$0.28 | -$0.71 | -$1.46 | $0.11 | $4.38 | $0.60 | $0.24 |
| USD/shares | $0.01 | $0.16 | $0.07 | -$0.02 | -$0.28 | -$0.71 | -$1.46 | $0.10 | $4.11 | $0.60 | $0.24 |
| shares | 2.17B | 855.29M | 141.52M | 68.6M | 59.61M | 48.84M | 48.76M | 48.69M | 14.99M | 14.11M | 14.03M |
| shares | 2.17B | 855.29M | 141.52M | 68.6M | 59.61M | 48.84M | 48.76M | 52.91M | 15.89M | 14.11M | 14.03M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2020: $3.99M in buybacks, $19.55M in dividends.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Health Devices Segment | $6,000,000 | — | — |
| Online Market Place Segment | $311,092 | $1,754,935 | $6,914,474 |
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Marketing Promotion Service | $13,835,063 | $14,366,602 | — | — | — | — | — |
| Revenue | $13,835,063 | $14,781,622 | $2,416,797 | $13,186,525 | — | — | — |
| Tax and Surcharges | -$3,159 | -$3,824 | -$2,459 | -$4,964 | — | — | — |
| Commission Revenue | — | — | — | — | $96,332 | — | — |
| Commission Services | — | — | — | — | — | $82,054 | — |
| Interest Income 1 | — | — | — | — | $215,393 | $1,690,448 | — |
| Interest | — | — | — | — | — | — | $3,043,096 |
| Other Revenues | — | — | — | — | — | — | $161,538 |
| Recommendation Service Revenues | — | — | — | — | — | — | $3,754,738 |
| Revenue from Sale of Medical Devices | — | $415,020 | $2,416,797 | $13,186,525 | — | — | — |
| Sale of Medical Devices | — | — | $2,416,797 | $13,186,525 | $6,000,000 | — | — |
| Sales of Medical Devices | — | — | — | $181,274 | — | — | — |
| Service Other | — | — | — | — | — | — | $3,916,276 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Health Devices Segment | $567,171 | — | — |
| Online Market Place Segment | -$16,504,925 | -$30,904,348 | -$48,105,690 |
Operating Margin by Segment (%)
| Component | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Health Devices Segment | 9.5% | — | — |
| Online Market Place Segment | -5305.5% | -1761% | -695.7% |